Gyre Therapeutics Inc Dividend
Gyre Therapeutics Inc Dividend history 11 years
Dividend Analysis of the Gyre Therapeutics Inc Stock
| Current dividend yield | 8.69 % |
| Dividendenrendite 5 Jahre | 2.82 % |
| Dividend Yield 10Y | 5.55 % |
| Payout 3Y | 1.7 % |
When does Gyre Therapeutics Inc pay a dividend?
| Year | Dividend | Ex-day & Payday |
Frequency | |
|---|---|---|---|---|
| Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
| 2022 |
$1.8
$1.8
|
Jan 13 2023
Jan 13 2023
Jan 12 2023
Jan 13 23
Jan 12 23 |
Jan 12 2023 |
Special dividend
Special div.
|
| 2022 |
$6.6393
$6.64
|
Sep 21 2022
Sep 21 2022
Sep 20 2022
Sep 21 22
Sep 20 22 |
Sep 20 2022 |
Special dividend
Special div.
|
| 2015 |
$72.9471
$72.95
|
Aug 20 2015
Aug 20 2015
Aug 19 2015
Aug 20 15
Aug 19 15 |
Aug 19 2015 |
-
-
|
How much dividend does Gyre Therapeutics Inc pay?
Gyre Therapeutics Inc most recently paid a dividend of $1.80. Gyre Therapeutics Inc paid a Dividend of $0.00 Per Share in the financial year 2025. With a stock price of $7.11 at Oct 02 2026, the current dividend yield is 0.00% (calculation: $0.00 / $7.11 = 0.00%). No special dividend was paid.
What is the Gyre Therapeutics Inc Dividend Yield and payout ratio?
The average Gyre Therapeutics Inc dividend yield over the last 5 years is 0.00% and the average over the last 10 years is 0.00%.
The payout ratio of Gyre Therapeutics Inc in relation to the last financial year is 0.00%. The payout ratio smoothed over 3 years is 0.00%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
| Metric | Gyre Therapeutics Inc |
|---|---|
| Current dividend yield | 0.00% |
| Dividend Yield 5Y | 0.00% |
| Dividend Yield 10Y | 0.00% |
| Payout 1Y | 0.00% |
| Payout 3Y | 0.00% |
Is the Gyre Therapeutics Inc dividend safe? Continuity & Dividend Growth
Is the Gyre Therapeutics Inc dividend safe?
Gyre Therapeutics Inc has been paying a dividend for 0 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.
The average for the last 10 years is -100.00%.
| Metric | Gyre Therapeutics Inc |
|---|---|
| Increased | 0 Years |
| Continuity | 0 Years |
| Paid | 0 Years |
| Growth 10Y | -100.00% |
Continuity
Gyre Therapeutics Inc has been paying a dividend for 0 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.
Dividend Growth
The average for the last 10 years is -100.00%.
Gyre Therapeutics Inc Stock Forecast 2026
On the stock exchange, the Gyre Therapeutics Inc stock (ISIN: US4037831033) is not traded as a top scorer in October 2026 according to the dividend strategy.
The stock price of Gyre Therapeutics Inc 4.11% has risen since the beginning of the year 2026. However, the return generated in the past says nothing about the future return. You can find the Gyre Therapeutics Inc stock price in real time at the top of the page.
Gyre Therapeutics Inc (symbol: GYRE) is valued at a Price / Earnings Ratio (P/E ratio) of -35.55 and a price/sales ratio (P/S ratio) of 6.32 valued. Based on analyst estimates, the Gyre Therapeutics Inc stock forecast 2026 of the current financial year corresponds to a valuation of -18.84 according to P/E ratio and 6.75 according to P/S.
| Metric | Gyre Therapeutics Inc |
|---|---|
| Dividend Score | ??/15 |
| Performance 2026 |
4.11%
|
| P/E TTM | -35.55 |
| P/S TTM | 6.32 |
| P/E forward | -18.84 |
| P/S forward | 6.75 |
Gyre Therapeutics Inc (symbol: GYRE) is valued at a Price / Earnings Ratio (P/E ratio) of -35.55 and a price/sales ratio (P/S ratio) of 6.32 valued. Based on analyst estimates, the Gyre Therapeutics Inc stock forecast 2026 of the current financial year corresponds to a valuation of -18.84 according to P/E ratio and 6.75 according to P/S.
Discover more Dividend Stocks in Germany, USA and Worldwide
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
